Director/PDMR Shareholding

Smith & Nephew Plc
03 November 2023
 

SMITH & NEPHEW PLC

 

3 November 2023

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2023 interim dividend payment on 1 November 2023.

Date of Transaction

2023 - 11 - 1

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

Director / PDMR

Price

Volume

Aggregated information

Helen Barraclough

(Group General Counsel and Company Secretary)

PDMR

£9.24546

378.63846

N/A Single Transaction

Bradley Cannon

(President, Global Orthopaedics)

PDMR

£9.24546

 4.70426

N/A Single Transaction

Paul Connolly

(President, Global Operations)

PDMR

£9.24546

 95.16781

N/A Single Transaction

Phil Cowdy

(Chief Corporate Development & Corporate Affairs Officer)

PDMR

£9.24546

 2.52246

N/A Single Transaction

Mizanu Kebede

(Chief Quality & Regulatory Affairs Officer)

PDMR

£9.24546

 50.47884

N/A Single Transaction

Deepak Nath

(Chief Executive Officer)

Director

£9.24546

 1,275.12874

N/A Single Transaction

Alison Parkes

(Chief Compliance Officer)

PDMR

£9.24546

 47.98799

N/A Single Transaction

Scott Schaffner

(President, Sports Medicine)

PDMR

£9.24546

 722.89052

N/A Single Transaction

 

 

 

 

Sarah Carne  

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings